SI

Signatur Biosciences

YC S22

London, GB · Founded 2022 · 5 employees · 1 known investors

signatur.bio ↗

Signatur Biosciences develops molecular diagnostic solutions using qPCR technology for in vitro diagnostics, targeting clinical and laboratory markets. The company aims to deliver advanced diagnostics on widely available instrumentation to expand access to cutting-edge healthcare globally.

Founders & leadership· Y Combinator alumni (S22)

John Goertzin𝕏Founder

Celestin de Wergifossein𝕏Founder

Cd

Celestin de WergifiosseCEO

PD

Prof Dame Molly StevensScientific Advisory Board Chair, Co-inventor

DJ

Dr John Goertz

Investors · 1

Y

Y CombinatorMountain View · $500K – $500K